# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizin...
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral&...
Shares of Abbott Laboratories (NYSE: ABT) are trading lower on Thursday following the company's announcement of its second-...
It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), ofte...
Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with ...
Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.’s (NYSE:TSM) strong ...